You can:
Name | 5-hydroxytryptamine receptor 7 |
---|---|
Species | Homo sapiens (Human) |
Gene | HTR7 |
Synonym | 5-HT-7 Serotonin receptor 7 5-HT-X 5-HT1Y 5-HT7 [ Show all ] |
Disease | Sleep disorders Schizophrenia Major depressive disorder |
Length | 479 |
Amino acid sequence | MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD |
UniProt | P34969 |
Protein Data Bank | N/A |
GPCR-HGmod model | P34969 |
3D structure model | This predicted structure model is from GPCR-EXP P34969. |
BioLiP | N/A |
Therapeutic Target Database | T79062 |
ChEMBL | CHEMBL3155 |
IUPHAR | 12 |
DrugBank | BE0000650, BE0004862 |
Name | CHEMBL316039 |
---|---|
Molecular formula | C21H26N4O |
IUPAC name | 2a-[4-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)butyl]-1,3,4,5-tetrahydrobenzo[cd]indol-2-one |
Molecular weight | 350.466 |
Hydrogen bond acceptor | 3 |
Hydrogen bond donor | 2 |
XlogP | 2.4 |
Synonyms | 2a-[4-(4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine-5-yl)butyl]-1,2,2a,3,4,5-hexahydrobenzo[cd]indol-2-on SCHEMBL6423050 |
Inchi Key | AECKIVMAUDSDRJ-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C21H26N4O/c26-20-21(10-4-6-15-5-3-7-17(24-20)19(15)21)9-1-2-11-25-12-8-16-18(13-25)23-14-22-16/h3,5,7,14H,1-2,4,6,8-13H2,(H,22,23)(H,24,26) |
PubChem CID | 18377342 |
ChEMBL | CHEMBL316039 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 562.34 nM | PMID12182857 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417